7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
NCT07175077 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-12-02
Summary
Comparison of a 7t MRI to standard of care 1.5t/3t MRI scans to determine if earlier detection of brain metastases are possible on a 7t.
Conditions
- Small-cell Lung Cancer
- Brain Metastases
Interventions
- DEVICE
-
7t MRI
7t brain MRI followed by up to 12 months of standard of care 1.5t/3t MRI scans
Sponsors & Collaborators
-
Siemens Medical Solutions
collaborator INDUSTRY -
University of Missouri-Columbia
lead OTHER
Principal Investigators
-
Bo Lu, MD · CHAIR & PROFESSOR, DEPARTMENT OF RADIATION ONCOLOGY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-01
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
NCT07319897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets
NCT02735798 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Automated Detection of Brain Metastases on MRI
NCT06727032 ·Status: ENROLLING_BY_INVITATION
-
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT04197297 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis
NCT01974804 ·Status: COMPLETED
-
PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells
NCT05176275 ·Status: UNKNOWN ·Phase: NA
-
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
NCT02201797 ·Status: COMPLETED ·Phase: NA
-
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
NCT02376127 ·Status: COMPLETED
-
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
NCT03680144 ·Status: COMPLETED ·Phase: NA
-
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05228106 ·Status: RECRUITING
-
MRI Perfusion on T1 and T2 Brain Lesion(s)
NCT02250755 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
NCT01266096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
NCT05376878 ·Status: RECRUITING ·Phase: PHASE4
-
Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
NCT03325166 ·Status: TERMINATED ·Phase: PHASE2
-
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
NCT04752267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Multiparametric/Multimodality for Lungcancer
NCT02977663 ·Status: UNKNOWN ·Phase: NA
-
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
NCT06428708 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
NCT06720207 ·Status: NOT_YET_RECRUITING
-
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
NCT05626127 ·Status: UNKNOWN
-
Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers
NCT02465723 ·Status: WITHDRAWN ·Phase: NA
-
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
NCT04320030 ·Status: COMPLETED ·Phase: PHASE2
-
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
NCT02277561 ·Status: WITHDRAWN ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
NCT04442724 ·Status: RECRUITING ·Phase: NA
-
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
NCT01621906 ·Status: COMPLETED ·Phase: NA